Effect of dabrafenib on melanoma cell lines harbouring the BRAF V600D/R mutations
© Gentilcore et al.; licensee BioMed Central Ltd. 2013
Received: 25 March 2012
Accepted: 13 November 2012
Published: 14 January 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|25 Mar 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|21 May 2012||Author responded||Author comments - Paolo A. Ascierto|
|Resubmission - Version 3|
|21 May 2012||Submitted||Manuscript version 3|
|1 Aug 2012||Reviewed||Reviewer Report - Richard Kefford|
|5 Oct 2012||Reviewed||Reviewer Report - Michael Davies|
|31 Oct 2012||Author responded||Author comments - Paolo A. Ascierto|
|Resubmission - Version 4|
|31 Oct 2012||Submitted||Manuscript version 4|
|13 Nov 2012||Editorially accepted|
|14 Jan 2013||Article published||10.1186/1471-2407-13-17|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.